FindTrial
Sign In

Breast cancer

P53 expression and its correlation with molecular classification of Invasive Breast Carcinoma - A cross sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048930
Enrollment
90
Registered
2023-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast

Interventions

Control Intervention1: Nil: Nil

Sponsors

Rohilkhand Medical College and Hospital, Bareilly
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All histopathologically diagnosed cases of Invasive breast carcinoma in which molecular classification has been done, in the Department of Pathology, Rohilkhand Medical College and Hospital, Bareilly

Exclusion criteria

Exclusion criteria: 1 Patient who received radiotherapy and chemotherapy. 2 Cases other than Invasive breast carcinoma.

Design outcomes

Primary

MeasureTime frame
To study the immunohistochemical expression of p53 Biomarker in cases of Invasive Breast Carcinoma and its correlation with various prognostic markers.Timepoint: After operative procedure.—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Neha Singh

Rohilkhand Medical college and hospital

dr.mithila@gmail.com7906080213

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026